Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 1.32M | 1.47M | 1.47M | 1.02M | 692.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32M | 1.47M | 1.47M | 1.02M | 692.50K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.32M | 1.47M | 1.47M | 1.02M | 692.50K |
| SG&A Expenses | 6.10M | 3.13M | 3.86M | 3.40M | 3.08M |
| Depreciation & Amortization | 115.60K | 115.60K | 35.60K | 35.60K | 35.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.21M | 3.25M | 3.89M | 3.44M | 3.11M |
| Operating Income | -4.89M | -1.78M | -2.42M | -2.42M | -2.42M |
| Income Before Tax | -5.08M | -2.04M | -2.75M | -2.73M | -2.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.08 | -2.04 | -2.75 | -2.73 | -2.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.08M | -2.04M | -2.75M | -2.73M | -2.72M |
| EBIT | -4.89M | -1.78M | -2.42M | -2.42M | -2.42M |
| EBITDA | -4.85M | -1.74M | -2.39M | -2.39M | -2.39M |
| EPS Basic | -15.40 | -4.14 | -12.15 | -16.62 | -16.60 |
| Normalized Basic EPS | -9.63 | -2.59 | -7.59 | -10.39 | -10.37 |
| EPS Diluted | -15.67 | -4.27 | -12.28 | -16.75 | -16.73 |
| Normalized Diluted EPS | -9.63 | -2.59 | -7.59 | -10.39 | -10.37 |
| Average Basic Shares Outstanding | 1.29M | 2.02M | 1.77M | 1.52M | 1.52M |
| Average Diluted Shares Outstanding | 1.29M | 2.02M | 1.77M | 1.52M | 1.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
